Novocure
NVCR
#5713
Rank
โ‚น123.47 B
Marketcap
Country
โ‚น1,056
Share price
-4.48%
Change (1 day)
5.67%
Change (1 year)
Categories

Earnings for Novocure (NVCR)

Earnings in 2026 (TTM): -โ‚น8.42 Billion

According to Novocure 's latest financial reports the company's current earnings are โ‚น0.72 Billion. In 2025 the company made an earning of -โ‚น11.15 Billion, an increase over its 2024 earnings that were of -โ‚น11.3 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Novocure from 2015 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚น8.42 Billion-24.44%
2025 -โ‚น11.15 Billion-1.33%
2024 -โ‚น11.3 Billion-35.88%
2023 -โ‚น17.61 Billion139.99%
2022 -โ‚น7.34 Billion61.43%
2021 -โ‚น4.55 Billion-235.99%
2020 โ‚น3.34 B630.75%
2019 โ‚น0.45 B-115.08%
2018 -โ‚น3.04 Billion-15.13%
2017 -โ‚น3.58 Billion-66.9%
2016 -โ‚น10.8 Billion10.26%
2015 -โ‚น9.8 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Organovo
ONVO
-โ‚น0.24 Billion-97.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Orchard Therapeutics
ORTX
-โ‚น6.83 Billion-18.78%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novavax
NVAX
-โ‚น20.89 Billion 148.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Novocure
NVCR
-โ‚น8.41 Billion 0.00% Jersey